JUNS - JUPITER NEUROSCIENCES, INC.
0.6009
-0.010 -1.648%
Share volume: 38,636
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.61
-0.01
-0.02%
View ratios
| Fiscal Date | 09-30-2023 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q3 2023 | Q3 2024 | Q4 2024 | |
| Report Date | 12-23-2024 | 12-23-2024 | 03-28-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 1.442 M | 493.547 K | 0.000 | |
| Selling general and admin | 1.203 M | 401.636 K | 0.000 | |
| Research and development | 239.458 K | 91.911 K | 0.000 | |
| Total expenses | 1.442 M | 493.547 K | 0.000 | |
| -65.78% | -100.00% | |||
| Operating income | -1.442 M | -493.547 K | 0.000 | |
| Ebit | -1.476 M | -483.662 K | 0.000 | |
| Pretax income | -1.774 M | -591.021 K | 0.000 | |
| -66.69% | -100.00% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.774 M | -591.021 K | 0.000 | |
| 66.69% | 100.00% |
